CD4 and glioblastoma: Moreover, immune profiling analysis of mouse GBM tumors by CyTOF showed that harmine treatment in vivo (Fig. 4C) stimulated T cell infiltration into the tumors, as indicated by robustly increased numbers of both CD4+ and CD8+ infiltrates.